Consumo y costo de sertralina en sus formas genérica y comercial en un Establecimiento Farmacéutico de Trujillo, Septiembre 2021 - Febrero 2022
No Thumbnail Available
Date
2022
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El presente informe de prácticas pre profesionales tuvo como objetivo determinar el consumo y costo de sertralina 50 mg en sus semejantes comerciales (Serlif y Eleval) de un Establecimiento Farmacéutico de Trujillo, Septiembre 2021 - Febrero 2022. Para dicho trabajo se ocupó dicha muestra de estudio en función al principio madre de sertralina 50 mg tabletas, en donde los datos de consumo de unidades dispensadas estuvieron dados en Dosis Diaria Definida (DDD) por 1000 habitantes por día. Dichos datos fueron recopilados de la base del sistema Pos Unificado versión 2.1. Los resultados se extrajeron en las tablas y figuras en donde pudimos observar tanto el consumo semestral expresado en Dosis Diaria Definida (DDD) por 1000 habitantes por día, siendo el consumo y costo mensual – semestral de unidades concedidas de dicho fármaco. Del estudio de los resultados llegamos a concluir que sertralina 50 mg fue el fármaco mas usado, con un total de 1270 unidades vendidas, además presentó un 0.1381 de DDD por 1000 habitantes por día y con un costo de S/. 0.60, en lo cual se llegó a una demanda de precio de S/. 762.00 en el transcurso de Septiembre 2021 – Febrero 2022.
ABSTRACT The objective of this report of pre-professional practices was to determine the consumption and cost of sertraline 50 mg in its commercial counterparts (Serlif and Eleval) of a Pharmaceutical Establishment in Trujillo, September 2021 - February 2022. For this work, said study sample was used. based on the mother principle of sertraline 50 mg tablets, where the consumption data of units dispensed were given in Defined Daily Dose (DDD) per 1000 inhabitants per day. These data were collected from the base of the Unified Pos system version 2.1. The results were extracted in the tables and figures where we could observe both the biannual consumption expressed in Defined Daily Dose (DDD) per 1000 inhabitants per day, being the monthly consumption and cost - biannual of granted units of said drug. From the study of the results we concluded that sertraline 50 mg was the most used drug, with a total of 1270 units sold, it also presented a DDD of 0.1381 per 1000 inhabitants per day and with a cost of S/. 0.60, in which a demand price of S/. 762.00 in the course of September 2021 – February 2022.
ABSTRACT The objective of this report of pre-professional practices was to determine the consumption and cost of sertraline 50 mg in its commercial counterparts (Serlif and Eleval) of a Pharmaceutical Establishment in Trujillo, September 2021 - February 2022. For this work, said study sample was used. based on the mother principle of sertraline 50 mg tablets, where the consumption data of units dispensed were given in Defined Daily Dose (DDD) per 1000 inhabitants per day. These data were collected from the base of the Unified Pos system version 2.1. The results were extracted in the tables and figures where we could observe both the biannual consumption expressed in Defined Daily Dose (DDD) per 1000 inhabitants per day, being the monthly consumption and cost - biannual of granted units of said drug. From the study of the results we concluded that sertraline 50 mg was the most used drug, with a total of 1270 units sold, it also presented a DDD of 0.1381 per 1000 inhabitants per day and with a cost of S/. 0.60, in which a demand price of S/. 762.00 in the course of September 2021 – February 2022.
Description
Keywords
Fármacos